Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Nov 12, 2019 · 10-Q · 43 days after period end · 0001401914-19-000090
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$3.39M | -$2.57M | -$1.63M | -$16.11K |
| EPS Diluted | -$0.20 | -$0.23 | -$0.33 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 12, 2019 · 43 d after period end
